Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Completed

Conditions studied: Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific

In brief

RATIONALE: New ways to find out about hearing loss after treatment with chemotherapy may improve the ability to plan cancer treatment and may help patients live more comfortably. PURPOSE: This clinical trial is assessing ear damage in young cancer patients treated with cisplatin.

Key facts

Study ID
NCT00458887
Run by
Children's Oncology Group
People needed
301
Starts
2007-05-01
Expected to finish
2017-02-28
Last updated by the study team
2017-03-13

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.